D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda et al., Immunization with amyloidbeta attenuates Alzheimer-disease-like pathology in the PDAPP mouse, Nature, vol.400, pp.173-177, 1999.

C. Janus, J. Pearson, J. Mclaurin, P. M. Mathews, Y. Jiang et al., A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease, Nature, vol.408, pp.979-982, 2000.

D. Morgan, D. M. Diamond, P. E. Gottschall, K. E. Ugen, C. Dickey et al., A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease, Nature, vol.408, pp.982-985, 2000.

J. A. Nicoll, D. Wilkinson, C. Holmes, P. Steart, H. Markham et al., Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report, Nat. Med, vol.9, pp.448-452, 2003.

I. Ferrer, M. Boada-rovira, M. L. Guerra, M. J. Rey, and F. Costajussá, Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease, Brain Pathol, vol.14, pp.11-20, 2004.

A. Kellner, J. Matschke, C. Bernreuther, H. Moch, I. Ferrer et al., Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden, Ann. Neurol, vol.65, pp.24-31, 2009.

C. Cao, G. W. Arendash, A. Dickson, M. B. Mamcarz, X. Lin et al., Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS, Neurobiol. Dis, vol.34, pp.63-70, 2009.

D. W. Ethell, D. Shippy, C. Cao, J. R. Cracchiolo, M. Runfeldt et al., Abeta-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice, Neurobiol. Dis, vol.23, pp.351-361, 2006.

A. Monsonego, V. Zota, A. Karni, J. I. Krieger, A. Bar-or et al., Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease, J. Clin. Invest, vol.112, pp.415-422, 2003.

V. Zota, A. Nemirovsky, R. Baron, Y. Fisher, D. J. Selkoe et al., HLA-DR alleles in amyloid betapeptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele, J. Immunol, vol.183, pp.3522-3530, 2009.

A. Monsonego, J. Imitola, S. Petrovic, V. Zota, A. Nemirovsky et al., Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease, Proc. Natl. Acad. Sci. USA, vol.103, pp.5048-5053, 2006.

R. Radde, T. Bolmont, S. A. Kaeser, J. Coomaraswamy, D. Lindau et al., Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology, EMBO Rep, vol.7, pp.940-946, 2006.

D. H. Cribbs, A. Ghochikyan, V. Vasilevko, M. Tran, I. Petrushina et al., Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid, Int. Immunol, vol.15, pp.505-514, 2003.

M. G. Agadjanyan, A. Ghochikyan, I. Petrushina, V. Vasilevko, N. Movsesyan et al., Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide, J. Immunol, vol.174, pp.1580-1586, 2005.

M. A. Kutzler, C. Cao, Y. Bai, H. Dong, P. Y. Choe et al., Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice, Vaccine, vol.24, pp.4630-4639, 2006.

D. Rosenkranz, S. Weyer, E. Tolosa, A. Gaenslen, D. Berg et al., Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration, J. Neuroimmunol, vol.188, pp.117-127, 2007.

S. Hussain, S. J. Kirwin, and S. A. Stohlman, Increased T regulatory cells lead to development of Th2 immune response in male SJL mice, Autoimmunity, vol.44, pp.219-228, 2011.

X. Chen, J. J. Oppenheim, and O. M. Howard, BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD252 responder T cells than C57BL/6 mice, J. Leukoc. Biol, vol.78, pp.114-121, 2005.

W. M. Bassuny, K. Ihara, Y. Sasaki, R. Kuromaru, H. Kohno et al., A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes, Immunogenetics, vol.55, pp.149-156, 2003.

Y. C. Lin, J. H. Lee, A. S. Wu, C. Y. Tsai, H. H. Yu et al., Association of single-nucleotide polymorphisms in FOXP3 gene with systemic lupus erythematosus susceptibility: a case-control study, Lupus, vol.20, pp.137-143, 2011.

L. Gao, K. Li, F. Li, H. Li, L. Liu et al., Polymorphisms in the FOXP3 gene in Han Chinese psoriasis patients, J. Dermatol. Sci, vol.57, pp.51-56, 2010.

Y. Ban, T. Tozaki, T. Tobe, Y. Ban, E. M. Jacobson et al., The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts, J. Autoimmun, vol.28, pp.201-207, 2007.

O. Park, P. S. Grishina, M. E. Leung, T. Gershwin, and . Prindiville, Analysis of the Foxp3/scurfin gene in Crohn's disease, Ann. N. Y. Acad. Sci, vol.1051, pp.218-228, 2005.

M. Pfeifer, S. Boncristiano, L. Bondolfi, A. Stalder, T. Deller et al., Cerebral hemorrhage after passive antiAbeta immunotherapy, Science, vol.298, p.1379, 2002.

D. R. Thakker, M. R. Weatherspoon, J. Harrison, T. E. Keene, D. S. Lane et al., Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice, Proc. Natl. Acad. Sci. USA, vol.106, pp.4501-4506, 2009.

S. Salloway, R. Sperling, S. Gilman, N. C. Fox, K. Blennow et al.,

, A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease, Clinical Trial Investigators, vol.73, pp.2061-2070, 2009.

C. Holmes, D. Boche, D. Wilkinson, G. Yadegarfar, V. Hopkins et al., Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial, Lancet, vol.372, pp.216-223, 2008.

M. Schwartz and R. Shechter, Systemic inflammatory cells fight off neurodegenerative disease, Nat. Rev. Neurol, vol.6, pp.405-410, 2010.

O. Butovsky, M. Koronyo-hamaoui, G. Kunis, E. Ophir, G. Landa et al., Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1, Proc. Natl. Acad. Sci. USA, vol.103, pp.11784-11789, 2006.

Y. Fisher, A. Nemirovsky, R. Baron, and A. Monsonego, T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease, PLoS ONE, vol.5, p.10830, 2010.

J. Kipnis, H. Avidan, R. R. Caspi, and M. Schwartz, Dual effect of CD4+ CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia, Proc. Natl. Acad. Sci. USA, vol.101, pp.14663-14669, 2004.